Status:
COMPLETED
Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy
Lead Sponsor:
Swiss Federal Institute of Technology
Collaborating Sponsors:
Mahidol University
Conditions:
Iron Deficiency Anemia of Pregnancy
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Iron deficiency anemia (IDA) is common during pregnancy and has adverse effects on the mother, fetus and newborn. Oral iron supplements are usually recommended to prevent ID/IDA during pregnancy. The...
Eligibility Criteria
Inclusion
- gestational week 14-16 at study start
- singleton pregnancy
- Serum ferritin SF \<60 µg/L
- non-anemic or mildly anemic, defined as hemoglobin (Hb) \>10 g/dL
- female aged 18-45 years
- healthy Thai woman
Exclusion
- acute or chronic disease
- taking medications that could influence iron absorption
- smoking
Key Trial Info
Start Date :
October 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04074707
Start Date
October 24 2019
End Date
June 30 2022
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahidol University
Salaya, Changwat Nakhon Pathom, Thailand, 73170